Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer

PURPOSE: Prostate specific antigen velocity is an unreliable predictor of adverse pathology findings in patients on active surveillance for low risk prostate cancer. However, to our knowledge a new concept called prostate specific antigen velocity risk count, recently validated in a screening cohort...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Urol
Main Authors: Patel, Hiten D., Feng, Zhaoyong, Landis, Patricia, Trock, Bruce J., Epstein, Jonathan I., Carter, H. Ballentine
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4711358/
https://ncbi.nlm.nih.gov/pubmed/24060641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2013.09.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados